PODD Conference

Mamata Majmundar, MD, Chief Medical Officer, EvryHealth

Gail Ryan, PharmD, Director of Pharmaceutical Transformation, Point32Health

Michael Sherman, MD, MBA, MS, Venture Partner, RA Capital

Mark Simon, MBA, Consultant, Stifel

9:25AM - 9:45AM

Drug Delivery Pipeline & Technologies, a Year in Review

Kurt Sedo, Vice President, PharmaCircle

Showing Events in 1 Track from 09:45am to 10:35am

Morning Networking Break

9:45AM - 10:35AM

PODD Networking Break & Partnering

Showing Events in 1 Track from 10:35am to 10:55am

Breakout A

10:35AM - 10:55AM

The Evolution of Technology and Key Challenges Being Addressed in Diabetes Care

Tony Bedford, Commercial Director, Platform Management & Innovation, Phillips-Medisize

Showing Events in 1 Track from 11:00am to 11:55pm

General Session

11:00AM - 11:30AM

The Realities of Developing Self Administration of Subcutaneous Therapeutics

Scott Ariagno, Vice President, Engineering & Development Services, EdgeOne Medical

Advait Badkar, PhD, Executive Director- Drug Product Design and Development & Head of Nanoparticle Development, Biotherapeutics Pharmaceutical Sciences, Pfizer

Sujit Basu, PhD, Head, Pharmaceutical Development, Ionis Pharmaceuticals

Courtney Nicholas Sutton, Associate Director, Device Development, AstraZeneca

Monica Adams, PhD, MBA, Global Head , Packaging, Device, and Design Solutions, GSK

11:30AM - 11:55PM

Industrialization of Dual Chamber Delivery Systems and Fill-Finish to Serve the Needs of Obesity and Diabetes Pipeline Therapies

Sherri Biondi, PhD, Senior Director and Head of Device Development, AstraZeneca

Joan Melé, Chief Commercial Officer, Dara

Moderators:

John Merhige, Chief Commercial Officer, Credence MedSystems

11:55AM - 12:40PM

PODD Annual Soapbox Presentations

Patrick Lim Soo, PhD, Associate Research Fellow, Pharmaceutical Research & Development, Pfizer

Hosted By:

Showing Events in 1 Track from 12:40pm to 01:55pm

Luncheon & Partnering Meetings

12:40PM - 1:55PM

Luncheon & Partnering Meetings

Showing Events in 3 Tracks from 02:00pm to 03:15pm

Cell & Gene Delivery

The Growing Impact of AI Approaches to Deliver Cell & Gene Therapy

Sean Bedingfield, PhD, R&D Advisor - Genetic Medicine, Eli Lilly and Company

Ashoka Madduri, PhD, MBA, Head of Scientific Strategy & Competitive Intelligence, mRNA Center of Excellence, Sanofi

Ester Caffarel-Salvador, PhD, Director, Strategic Innovation, Rare Diseases, Chiesi USA

Novel Cell Therapy: Advances in Targeting and Payload Delivery

Kanika Suri, PhD, Scientist, Drug Product Development, CMC, Takeda Pharmaceuticals

Shankar Swaminathan, PhD, Associate Director, Drug Product Development, Astellas Institute for Regenerative Medicine, Astellas Pharma

Excipients and Manufacturing

Improving Bioavailability and Stability Through Excipient Innovation

Milin Shah, RPh, PhD, Associate Director, Gilead Sciences

Liping Zhou, PhD, Senior Director, Advanced Drug Delivery, AstraZeneca

Monica Swinney, PhD, Senior Director, New Product Planning & Drug Delivery Innovation, Gilead Sciences

Designing and Developing Drug Delivery for LMICs

Tycho Speaker, PhD, Senior Principal Research Scientist, Combination Product Development and Drug Delivery, AbbVie

Joseph (Joe) Wojcik, MBA, PMP, Senior Director, Pharmaceutical Development Services, ApiJect

Combination Devices

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

Lindsey Crawford, PhD, Senior Principal Scientist, Pfizer

Dany Doucet, PhD, Director of the Early Engagement and Deviceability, GSK

E Guan, PhD, Head of Injection Systems, Takeda

Nicholas Schill, PhD, Senior Director, Product Development, Kymanox

Christian Jones, Chief Commercial Officer, Nanoform

Accelerating Evaluations of New Device Technologies for Complex Formulations

Khaudeja Bano, MD, Vice President Combination Product, Devices, Diagnostics and Software, Amgen

Jason Durkin, VP of Supply Chain, Windgap Medical

Gabrielle Gehron, Technical and Scientific Expert, Datwyler Pharma Packaging USA Inc.

Sindhuja Kuchibhatla, Senior Manager, Device Technology & Innovation, GSK

Josh Horvath, PhD, Senior Director, Device & Packaging Development, Genentech

Showing Events in 1 Track from 03:15pm to 03:30pm

Afternoon Networking Break

3:15PM - 3:30PM

Afternoon Networking Break

Showing Events in 3 Tracks from 03:30pm to 05:00pm

Targeted and Long Acting Delivery

Sustained Release Innovations to Reduce Patient Burden

Manish Gupta, PhD, Executive Director R&D, Drug Product Development - Steriles, GSK

Elham Nejati, PhD, Director of Formulation and Process Development Department, Gilead Sciences

Bin Wu, PhD, Founder, Phosphorex

Stephen Buckley, PhD, Vice President, Advanced Drug Delivery, Novo Nordisk

Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches

New Approaches to Achieve BBB Permeability without Increasing Toxicity

Darren Reid, PhD, Director, Process Development, Amgen

Novel Modalities

Advances in Pulmonary Delivery of Biologics

Alessandro Cavecchi, M.Sc., Head of Pharmaceutical Technology, Chiesi Farmaceutici S.p.A.

Philippe Rogueda, PhD, FRSC, CChem, CSci, Chief Business Officer, Merxin Ltd

Michael Song, PhD, Director, Moderna

Vaccine Delivery Innovations

Derek O'Hagan, Senior Advisor Vaccines R&D, GSK

Patrick Lim Soo, PhD, Associate Research Fellow, Pharmaceutical Research & Development, Pfizer

Focused Ultrasound Delivery for CNS: Clinical Trials and Beyond

Sudhakar Garad, PhD, Global Head of Chemical and Pharmaceutical Profiling, Novartis

Elise Konofagou, PhD, Robert and Margaret Hariri Professor of Biomedical Engineering, Professor of Radiology (Physics) Department of Biomedical Engineering, Columbia University

Novel Devices

Translating Digital Health from the Clinic to Market Access and Commercial Success

Beate Bittner, PhD, Senior Portfolio Strategy Director, Roche

Matthew Keiser, MS, Director, Core Team Leader & Industrialization Lead; Device & Connected Solution Engineering; Global Healthcare Operations, EMD Serono

Vince Masciopinto, Customer Solutions Director, SHL Medical

Paul Upham, Head, Smart Devices, Genentech

Lessons Learned in the Development and Introduction of Closed Loop Systems and Companion Diagnostics

Henrik Bengtsson, E-MBA, Senior Innovation Lead (Director), Novo Nordisk

Biomaterial Implants to Reduce Patient Burden and Improve Adherence

Eileen Sadeghi, PhD, Senior Scientist II, AbbVie

Jaymin Shah, PhD, Senior Research Fellow and Head of Global Bioharmaceutics, Pharmaceutical Sciences Small Molecules, Pfizer

Showing Events in 1 Track from 05:00pm to 05:05pm

PODD Conference Concludes

5:00PM - 5:05PM

PODD Conference Concludes

Showing Events in 1 Track from 08:20am to 08:30am

Morning General Session

8:20AM - 8:30AM

Co-Chairs' Opening Remarks

Co-Chairs:

Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership

Sherri Biondi, PhD, Senior Director and Head of Device Development, AstraZeneca

Aly Jackson, MS, MBA, Business Development Project Leader, Genentech / Roche

Showing Events in 1 Track from 08:30am to 08:55am

Keynote Presentation

8:30AM - 8:55AM

Keynote Presentation: The Evolution of Delivery Approaches for In Vivo Gene Editing to Achieve Meaningful Clinical Impact

Keynote:

Laura Sepp-Lorenzino, PhD, Chief Scientific Officer, Intellia Therapeutics

Showing Events in 1 Track from 08:55am to 09:45am

Morning General Session

8:55AM - 9:25AM

Payer Perspectives on Drug Delivery

Mamata Majmundar, MD, Chief Medical Officer, EvryHealth

Gail Ryan, PharmD, Director of Pharmaceutical Transformation, Point32Health

Michael Sherman, MD, MBA, MS, Venture Partner, RA Capital

Mark Simon, MBA, Consultant, Stifel

9:25AM - 9:45AM

Drug Delivery Pipeline & Technologies, a Year in Review

Kurt Sedo, Vice President, PharmaCircle

Showing Events in 1 Track from 09:45am to 10:35am

Morning Networking Break

9:45AM - 10:35AM

PODD Networking Break & Partnering

Showing Events in 1 Track from 10:35am to 10:55am

Breakout A

10:35AM - 10:55AM

The Evolution of Technology and Key Challenges Being Addressed in Diabetes Care

Tony Bedford, Commercial Director, Platform Management & Innovation, Phillips-Medisize

Showing Events in 1 Track from 11:00am to 11:55pm

General Session

11:00AM - 11:30AM

The Realities of Developing Self Administration of Subcutaneous Therapeutics

Scott Ariagno, Vice President, Engineering & Development Services, EdgeOne Medical

Advait Badkar, PhD, Executive Director- Drug Product Design and Development & Head of Nanoparticle Development, Biotherapeutics Pharmaceutical Sciences, Pfizer

Sujit Basu, PhD, Head, Pharmaceutical Development, Ionis Pharmaceuticals

Courtney Nicholas Sutton, Associate Director, Device Development, AstraZeneca

Monica Adams, PhD, MBA, Global Head , Packaging, Device, and Design Solutions, GSK

11:30AM - 11:55PM

Industrialization of Dual Chamber Delivery Systems and Fill-Finish to Serve the Needs of Obesity and Diabetes Pipeline Therapies

Sherri Biondi, PhD, Senior Director and Head of Device Development, AstraZeneca

Joan Melé, Chief Commercial Officer, Dara

Moderators:

John Merhige, Chief Commercial Officer, Credence MedSystems

11:55AM - 12:40PM

PODD Annual Soapbox Presentations

Patrick Lim Soo, PhD, Associate Research Fellow, Pharmaceutical Research & Development, Pfizer

Hosted By:

Showing Events in 1 Track from 12:40pm to 01:55pm

Luncheon & Partnering Meetings

12:40PM - 1:55PM

Luncheon & Partnering Meetings

Showing Events in 3 Tracks from 02:00pm to 03:15pm

Cell & Gene Delivery

The Growing Impact of AI Approaches to Deliver Cell & Gene Therapy

Sean Bedingfield, PhD, R&D Advisor - Genetic Medicine, Eli Lilly and Company

Ashoka Madduri, PhD, MBA, Head of Scientific Strategy & Competitive Intelligence, mRNA Center of Excellence, Sanofi

Ester Caffarel-Salvador, PhD, Director, Strategic Innovation, Rare Diseases, Chiesi USA

Novel Cell Therapy: Advances in Targeting and Payload Delivery

Kanika Suri, PhD, Scientist, Drug Product Development, CMC, Takeda Pharmaceuticals

Shankar Swaminathan, PhD, Associate Director, Drug Product Development, Astellas Institute for Regenerative Medicine, Astellas Pharma

Excipients and Manufacturing

Improving Bioavailability and Stability Through Excipient Innovation

Milin Shah, RPh, PhD, Associate Director, Gilead Sciences

Liping Zhou, PhD, Senior Director, Advanced Drug Delivery, AstraZeneca

Monica Swinney, PhD, Senior Director, New Product Planning & Drug Delivery Innovation, Gilead Sciences

Designing and Developing Drug Delivery for LMICs

Tycho Speaker, PhD, Senior Principal Research Scientist, Combination Product Development and Drug Delivery, AbbVie

Joseph (Joe) Wojcik, MBA, PMP, Senior Director, Pharmaceutical Development Services, ApiJect

Combination Devices

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

Lindsey Crawford, PhD, Senior Principal Scientist, Pfizer

Dany Doucet, PhD, Director of the Early Engagement and Deviceability, GSK

E Guan, PhD, Head of Injection Systems, Takeda

Nicholas Schill, PhD, Senior Director, Product Development, Kymanox

Christian Jones, Chief Commercial Officer, Nanoform

Accelerating Evaluations of New Device Technologies for Complex Formulations

Khaudeja Bano, MD, Vice President Combination Product, Devices, Diagnostics and Software, Amgen

Jason Durkin, VP of Supply Chain, Windgap Medical

Gabrielle Gehron, Technical and Scientific Expert, Datwyler Pharma Packaging USA Inc.

Sindhuja Kuchibhatla, Senior Manager, Device Technology & Innovation, GSK

Josh Horvath, PhD, Senior Director, Device & Packaging Development, Genentech

Showing Events in 1 Track from 03:15pm to 03:30pm

Afternoon Networking Break

3:15PM - 3:30PM

Afternoon Networking Break

Showing Events in 3 Tracks from 03:30pm to 05:00pm

Targeted and Long Acting Delivery

Sustained Release Innovations to Reduce Patient Burden

Manish Gupta, PhD, Executive Director R&D, Drug Product Development - Steriles, GSK

Elham Nejati, PhD, Director of Formulation and Process Development Department, Gilead Sciences

Bin Wu, PhD, Founder, Phosphorex

Stephen Buckley, PhD, Vice President, Advanced Drug Delivery, Novo Nordisk

Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches

New Approaches to Achieve BBB Permeability without Increasing Toxicity

Darren Reid, PhD, Director, Process Development, Amgen

Novel Modalities

Advances in Pulmonary Delivery of Biologics

Alessandro Cavecchi, M.Sc., Head of Pharmaceutical Technology, Chiesi Farmaceutici S.p.A.

Philippe Rogueda, PhD, FRSC, CChem, CSci, Chief Business Officer, Merxin Ltd

Michael Song, PhD, Director, Moderna

Vaccine Delivery Innovations

Derek O'Hagan, Senior Advisor Vaccines R&D, GSK

Patrick Lim Soo, PhD, Associate Research Fellow, Pharmaceutical Research & Development, Pfizer

Focused Ultrasound Delivery for CNS: Clinical Trials and Beyond

Sudhakar Garad, PhD, Global Head of Chemical and Pharmaceutical Profiling, Novartis

Elise Konofagou, PhD, Robert and Margaret Hariri Professor of Biomedical Engineering, Professor of Radiology (Physics) Department of Biomedical Engineering, Columbia University

Novel Devices

Translating Digital Health from the Clinic to Market Access and Commercial Success

Beate Bittner, PhD, Senior Portfolio Strategy Director, Roche

Matthew Keiser, MS, Director, Core Team Leader & Industrialization Lead; Device & Connected Solution Engineering; Global Healthcare Operations, EMD Serono

Vince Masciopinto, Customer Solutions Director, SHL Medical

Paul Upham, Head, Smart Devices, Genentech

Lessons Learned in the Development and Introduction of Closed Loop Systems and Companion Diagnostics

Henrik Bengtsson, E-MBA, Senior Innovation Lead (Director), Novo Nordisk

Biomaterial Implants to Reduce Patient Burden and Improve Adherence